IPO
Integral makes partial exit from Japan's Skymark
Japanese private equity firm Integral Corporation has sold most of its remaining position in Skymark Airlines, the budget air carrier it took public in December last year.
China GP Tiantu Capital targets $253m Hong Kong IPO
Chinese consumer-focused venture capital firm Tiantu Capital has launched a Hong Kong IPO with a view to raising as much as HKD 1.9bn (USD 253m).
Japan's Integral files for IPO
Japanese private equity firm Integral Corporation has been approved to go public on the Tokyo Stock Exchange via an IPO that could raise up to JPY 29.3bn (USD 201m).
China's Keep raises $40m in Hong Kong IPO
Keep, a China-focused fitness app operator backed by the likes of GGV Capital, SoftBank Vision Fund 2, and 5Y Capital, traded up slightly on debut after raising HKD 313.5m (USD 40m) in a smaller-than-anticipated Hong Kong IPO.
Fund focus: Epiq renews brute force India tech strategy
Epiq Capital has closed its second VC fund aimed at identifying India’s future tech unicorns early and buying in when the path to a large IPO comes into focus. Access and selection are the secret sauce
Carlyle-backed Adicon trades up after $52m Hong Kong IPO
Adicon Holdings, a China-based independent clinical laboratory (ICL) services provider backed by The Carlyle Group, gained 12% on debut following a HKD 408.9m (USD 52.2m) Hong Kong IPO.
HKEX relaxes rules for IPOs by pre-profit tech companies
The Hong Kong Stock Exchange (HKEX) has loosened its listing requirements to allow pre-profit technology companies to go public with market capitalisations as low as HKD 6bn (USD 764m).
China's Welkin Capital targets London IPO
China-focused Welkin Capital is looking to raise up to USD 300m through an IPO for a London-listed investment entity seeded with assets from its debut private equity fund, which closed in 2017.
PE-backed Gogox sinks on debut after $98m Hong Kong IPO
Gogox, a last-mile logistics company formed through the merger of Hong Kong's GoGoVan and an affiliate of mainland China-based 58.com, fell 22% on its Hong Kong trading debut following a HKD 771.4 (USD 98.3m) IPO.
Asia PE investment hits new high in 2021
A rebound in China-based activity took Asia private equity investment to a record USD 105.3bn in the fourth quarter, ensuring that 2021 represents a new high watermark for the industry.
Biotech player CANbridge drops on debut after $87m HK IPO
CANbridge Pharmaceuticals, a Beijing-based drug developer that focuses on treatments for cancer and rare diseases, lost 27% in value on its Hong Kong trading debut following a HK$685.1 million ($87.8 million) IPO.